PubMed HealthSearch

PubMed · 3145822

Decrease of urine creatinine in vitro in spinal cord injury patients.

Abstract

Freshly voided urine from 3 spinal cord injury (SCI) patients showed a progressive decline in creatinine concentration over 2 weeks while maintained in the refrigerator. Urine creatinine concentration remained stable in normals, patients with kidney disease and 9 other SCI patients. Mixtures of affected and normal urine showed a progressive decline in creatinine. Boiling or filtering prevented the decline while light centrifugation enhanced the decrease in the sediment but minimized it in the supernatant. Streptococcus fecalis was cultured from all 3 patients' urine, and produced a dramatic fall in creatinine concentration on incubation in broth with creatinine, as well as when added to normal urine. In the refrigerator, however, S. fecalis added to broth with creatinine, as well as to urine did not produce significant fall in creatinine concentration. Thus in certain SCI patients creatinine concentration decreases even when freshly obtained urine is maintained in the refrigerator. The cause of the fall in creatinine may relate to the presence of S. fecalis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D G Kaw, E Levy, T Kahn. 1988. Decrease of urine creatinine in vitro in spinal cord injury patients.. https://pubmed.ncbi.nlm.nih.gov/3145822/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Screening for neuroblastoma in the north of England.

OBJECTIVE: To determine the feasibility of establishing a system of screening for neuroblastoma. DESIGN: Prospective study of mass screening in four clearly defined geographical areas. SETTING: Four health districts of the Northern region of England. SUBJECTS: 20,829 babies aged 6 months, 92% of target population. INTERVENTIONS: Collection of urine on filter paper for analysis of content of homovanillic and vanillylmandelic acid in relation to urinary creatinine concentrations. MAIN OUTCOME MEASURES: Derivation of reference range. Identification of babies with homovanillic or vanillylmandelic acid > 3 SD above the mean (positive cases). Investigation of positive cases for evidence of neuroblastoma. RESULTS: The upper limit of normal (3 SD above the mean) for vanillylmandelic acid was 15 mumol/mmol creatinine and for homovanillic acid 24 mumol/mmol creatinine. Of the 20,829 babies screened, 2537 (12.2%) required a second sample to be taken because the first sample was inadequate. Of these, 527 (2.5%) provided a liquid urine specimen and 10 (0.04%) had positive results for neuroblastoma. Two of them had neuroblastoma (true positives) and eight did not (false positives). A further three children from the cohort were subsequently found to have neuroblastoma; they had raised homovanillic acid or vanillylmandelic acid values, or both, but screened negative at 6 months. CONCLUSIONS: Screening for neuroblastoma is possible in the health care system of the United Kingdom. Evaluation of the efficacy of screening in reducing the mortality from neuroblastoma requires a controlled trial.

Creatinine

More on SI units.

Explore the source record for details and available documents.

Creatinine